Keystone Symposia

This meeting took place in 2013



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Nutrition, Epigenetics and Human Disease (B5)


Organizer(s) Robert A. Waterland, David S. Rosenblatt and Patrick J. Stover
February 19—24, 2013
Hilton Santa Fe Historic Plaza Hotel • Santa Fe, NM USA
Abstract Deadline: Oct 17, 2012
Late Abstract Deadline: Nov 19, 2012
Scholarship Deadline: Oct 17, 2012
Early Registration Deadline: Dec 17, 2012

Sponsored by Cell Research, Nestlé Institute of Health Sciences and Takeda Pharmaceutical Company Limited

Summary of Meeting:
Transient nutritional exposures during critical developmental periods can induce permanent alterations in epigenetic regulation which program metabolic and other biological networks, with lifelong consequences. During other life stages nutrition can dynamically regulate epigenetic processes. There is increasing evidence that gene-nutrient interactions underlie susceptibility to various human diseases, through mechanisms that include interindividual variation in epigenomic profiles. The interaction of nutrition, epigenetics, and human disease is a rapidly evolving area of research with many fundamental outstanding questions and abundant opportunities to translate basic science discoveries to clinical and public health application. A meeting that brings together leaders in human nutrition, human genetics and epigenetics, clinical and animal studies of disease pathogenesis, inborn errors of metabolism, methyl metabolism, stem cell programming, genome stability, transcription, and developmental biology will accelerate and potentially transform research in this field.

View Meeting Program

Scholarships/Awards


Keystone Symposia Future of Science Fund Scholarship Recipients


Lyda L. Williams
Albert Einstein College of Medicine, USA

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institute on Aging (NIA) Scholarship Recipients


Joeva Jade Barrow
Harvard/Dana Farber Cancer Institute, USA

Matthew V. Cannon
Cleveland Clinic Lerner Research Institute, USA

Clara Y. Cheong
Singapore Institute for Clinical Sciences, Singapore

Elena Ivanova
Babraham Institute, UK

Elizabeth Radford
University of Cambridge, UK

Stephanie-May Ruchat
Université de Sherbrooke, Canada

Maria Soloveychik
University of Toronto, Canada